Axonics, Inc. - Common Stock (AXNX)
70.98
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 12:15 AM EDT

Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors.
Via InvestorPlace · July 22, 2024

AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · April 30, 2024

Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major surgery or resulting in prolonged hospitalization.
Via Benzinga · April 18, 2024

Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024.
Via Benzinga · January 31, 2024

The medical device maker agreed to be acquired by Boston Scientific.
Via The Motley Fool · January 8, 2024

Via Benzinga · January 8, 2024

Via Benzinga · December 22, 2023

The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
Via Investor's Business Daily · January 12, 2024

The Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via Benzinga · January 11, 2024

Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch.
Via InvestorPlace · January 9, 2024

The company showed improved revenue and margins in its second-quarter report.
Via The Motley Fool · July 28, 2023

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
Via Benzinga · January 8, 2024

Crocs stock is heading higher on Monday with heavy trading of CROX shares after the company posted a strong outlook for 2024!
Via InvestorPlace · January 8, 2024

Axonics stock is rising higher on Monday as investors react to a $71 per share cash offer for AXNX stock from Boston Scientific.
Via InvestorPlace · January 8, 2024

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $7
Via Benzinga · January 8, 2024

The year's biggest medical conference kicked off with a melee of buyout news.
Via Investor's Business Daily · January 8, 2024

Via Benzinga · January 8, 2024

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via Benzinga · October 30, 2023

Via Benzinga · July 19, 2023